迪安診斷(300244.SZ)預計2020年淨利7.12億元-8.16億元 同比增長105%-135%
格隆匯1月27日丨迪安診斷(300244.SZ)披露2020年度業績預吿,公司預計2020年度實現歸屬於上市公司股東的淨利潤7.12億元-8.16億元,同比增長105%-135%。業績增長原因系:
1、報吿期內,新冠肺炎疫情爆發,公司依託已有的業務佈局,全國一盤棋,高效助力各省市抗疫防疫攻堅,新冠檢測業務增量明顯;隨着國內疫情防控成果不斷鞏固,醫院門診量逐步恢復,公司堅守“以客户為中心,以臨牀為導向”,加大研發投入,推動學科和技術的驅動,傳統檢驗業務和產品代理業務也彈性回升。同時,公司持續加強精益管理,優化運營效率,經營性現金流量淨額約15億元,較上年同期大幅增長,營業收入和淨利潤亦呈現健康強勁增長態勢。
2、公司主要商譽形成是為了順應以公立為主的醫療體制特質及醫保控費下價值醫療的發展趨勢,強化行業內獨有的“服務+產品”一體化商業模式的競爭優勢,從而收購優質渠道商所構成。公司現已完成了渠道和檢驗在團隊、文化、管理、業務及供應鏈等各維度的協同和融合,真正整體化解決方案的差異化競爭優勢逐漸凸顯,但2020年受新冠疫情的一定影響,根據相關收購子公司的年度經營情況,出於謹慎性原則,公司對商譽資產進行了初步減值測試,預計計提商譽減值準備約4.2億-4.5億元。最終金額待審計、評估機構進行審評後方可確定。
3、預計2020年度非經常性損益對歸屬於上市公司股東淨利潤的影響金額約為5000萬元-6200萬元,基本為對外投資股權處置收益及收到的政府補助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.